학술논문
Phase 1 trial of an intranasal respiratory syncytial virus (rsv) subunit candidate vaccine: safety results from the muc-syngem study: S68
Document Type
Academic Journal
Author
Source
Thorax. Dec 01, 2017 72 Suppl 3:A43-A44
Subject
Language
English
ISSN
0040-6376